An Extension Study to Evaluate the Long-Term Safety of Lampalizumab in Participants With Geographic Atrophy
Clinical trial NCT01602120 · TERMINATED
Trial details
- NCT number
- NCT01602120
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-29
- Primary completion
- 2017-11-08
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.